Cytosorbents Crp Financial Flexibility Index
Cytosorbents Crp financial flexibility index. Cytosorbents Crp (CTSO) has a Financial Flexibility Index of -0.04x as of June 2026. Free cash flow of $-1.72 Million (operating CF $-1.75 Million minus capex $25.00K) represents 0% of total liabilities ($38.71 Million). See Cytosorbents Crp free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Cytosorbents Crp (2004–2025)
Financial flexibility index of Cytosorbents Crp from 2004 to 2025. Historical Financial Flexibility Index trend for Cytosorbents Crp across 22 annual periods. Check earnings quality score of Cytosorbents Crp to evaluate the quality of earnings relative to operating cash generation.
Cytosorbents Crp Financial Flexibility Index by Year (2004–2025)
Cytosorbents Crp financial flexibility index by year from 2004 to 2025. Year-by-year free cash flow to debt coverage for Cytosorbents Crp. For the full cash flow conversion analysis, see CTSO cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.32x | $-12.21 Million | $-12.38 Million | $38.28 Million | ▲ +18.2% |
| 2024 | -0.39x | $-14.14 Million | $-14.43 Million | $36.26 Million | ▲ +43.6% |
| 2023 | -0.69x | $-20.72 Million | $-21.66 Million | $29.99 Million | ▲ +11.6% |
| 2022 | -0.78x | $-21.78 Million | $-28.23 Million | $27.86 Million | ▼ -116.6% |
| 2021 | -0.36x | $-9.72 Million | $-14.01 Million | $26.94 Million | ▲ +1.6% |
| 2020 | -0.37x | $-3.94 Million | $-5.61 Million | $10.73 Million | ▲ +42.3% |
| 2019 | -0.64x | $-15.24 Million | $-16.76 Million | $23.96 Million | ▼ -7.9% |
| 2018 | -0.59x | $-9.32 Million | $-10.84 Million | $15.81 Million | ▼ -70.6% |
| 2017 | -0.35x | $-4.78 Million | $-6.46 Million | $13.84 Million | ▲ +42.7% |
| 2016 | -0.60x | $-6.14 Million | $-6.73 Million | $10.17 Million | ▲ +78.0% |
| 2015 | -2.75x | $-8.37 Million | $-9.01 Million | $3.04 Million | ▼ -96.8% |
| 2014 | -1.40x | $-6.29 Million | $-6.66 Million | $4.51 Million | ▼ -681.5% |
| 2013 | -0.18x | $-3.27 Million | $-3.49 Million | $18.31 Million | ▲ +25.2% |
| 2012 | -0.24x | $-3.58 Million | $-3.62 Million | $14.96 Million | ▲ +88.6% |
| 2011 | -2.09x | $-3.78 Million | $-3.83 Million | $1.80 Million | ▼ -107.9% |
| 2010 | -1.01x | $-2.31 Million | $-2.48 Million | $2.30 Million | ▲ +63.3% |
| 2009 | -2.74x | $-2.66 Million | $-2.67 Million | $970.76K | ▼ -20.2% |
| 2008 | -2.28x | $-2.34 Million | $-2.37 Million | $1.03 Million | ▲ +20.3% |
| 2007 | -2.86x | $-2.59 Million | $-2.63 Million | $906.87K | ▼ -11.2% |
| 2006 | -2.57x | $-2.78 Million | $-2.85 Million | $1.08 Million | ▼ -424.8% |
| 2005 | -0.49x | $-50.00K | $-50.00K | $101.97K | ▲ +11.7% |
| 2004 | -0.56x | $-50.00K | $-50.00K | $90.00K | — |